Bispecific T cell engager-armed T cells targeting integrin ανβ6 exhibit enhanced T cell redirection and antitumor activity in cholangiocarcinoma

Authors: Suwanchiwasiri, Kwanpirom ^{a, b, c}, Phanthaphol, Nattaporn ^{b, c, d, ⁎}, Somboonpatarakun, Chalermchai ^{b, c}, Yuti, Pornpimon ^{b, c}, Sujjitjoon, Jatuporn ^{b, c}, Luangwattananun, Piriya ^{b, c}, Maher, John ^e, Yenchitsomanus, Pa‑thai ^{b, c}, Junking, Mutita ^{b, c, ⁎⁎}

Source: In Biomedicine & Pharmacotherapy June 2024 175

Cytotoxicity of fourth-generation anti-Trop2 CAR-T cells against breast cancer

Authors: Somboonpatarakun, Chalermchai, Phanthaphol, Nattaporn, Suwanchiwasiri, Kwanpirom, Ramwarungkura, Boonyanuch, Yuti, Pornpimon, Poungvarin, Naravat, Thuwajit, Peti, Junking, Mutita, Yenchitsomanus, Pa-thai

Source: In International Immunopharmacology 10 March 2024 129

Chimeric Antigen Receptor T Cells Targeting Integrin αvβ6 Expressed on Cholangiocarcinoma Cells.

Authors: Phanthaphol, Nattaporn, Somboonpatarakun, Chalermchai, Suwanchiwasiri, Kwanpirom, Chieochansin, Thaweesak, Sujjitjoon, Jatuporn, Wongkham, Sopit, Maher, John, Junking, Mutita, Yenchitsomanus, Pa-thai

Source: Frontiers in Oncology; 3/3/2021, pN.PAG-N.PAG, 13p

Subject Terms: CHIMERIC antigen receptors, T cell receptors, INTEGRINS, CHOLANGIOCARCINOMA, T cells, FOOT & mouth disease